Market Overview

UPDATE: Deutsche Bank Raises PT on Mead Johnson Nutrition Co. on Continued Positive Outlook

Share:
Related MJN
Goldman's Top 25 Tactical Trades For Earnings Season
Credit Suisse Reiterates Outperform, Raises Price Target On Mead Johnson Nutrition On Multiple Positive Factors

In a report published Monday, Deutsche Bank analyst Greg Poole reiterated a Buy rating on Mead Johnson Nutrition Co. (NYSE: MJN), and raised the price target from $86.00 to $94.00.

In the report, Deutsche Bank noted, “Despite a number of unexpected challenges the last 2 years, largely from China, we have been steadfast in our positive view. We still see potential upside based on China remaining a growth area, non-China EM ramping up, an eventual U.S. recovery, along with reasonable global CPG valuation and shareholder returns. We retain our BUY opinion.”

Mead Johnson Nutrition Co. closed on Friday at $85.58.

Latest Ratings for MJN

DateFirmActionFromTo
Jan 2015CitigroupMaintainsBuy
Jan 2015Morgan StanleyMaintainsEqual-weight
Jan 2015NomuraInitiates Coverage onBuy

View More Analyst Ratings for MJN
View the Latest Analyst Ratings

Posted-In: Deutsche Bank Greg PooleAnalyst Color Price Target Analyst Ratings

 

Related Articles (MJN)

Around the Web, We're Loving...